A study posted to the bioRxiv* preprint server tested the hypothesis that the angiotensin-converting enzyme 2 (ACE-2) receptor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is not ...
In more than 3 million people worldwide treated for hypertension, ARBs were not only just as effective as ACE inhibitors at reducing the risk of major cardiovascular events, but also associated with a ...
April 26 (UPI) --Taking a specific type of blood pressure medication increases levels of a protein that helps COVID-19 spread through the body, a study presented Monday during the American Society for ...
The new data, published this week in JAMA Network Open, show that after adjusting for multiple variables, COVID-19 patients treated with ACE inhibitors and ARBs had a significantly lower risk of death ...
Data were gathered from 464 hypertensive subjects from YOH family genetic study. 17 This family study has been approved by the Human Investigation Committee of the Institute of Biomedical Sciences, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback